0000905718-16-001680.txt : 20160930 0000905718-16-001680.hdr.sgml : 20160930 20160930161341 ACCESSION NUMBER: 0000905718-16-001680 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160930 DATE AS OF CHANGE: 20160930 EFFECTIVENESS DATE: 20160930 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Roka BioScience, Inc. CENTRAL INDEX KEY: 0001472343 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 270881542 STATE OF INCORPORATION: DE FISCAL YEAR END: 1216 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-271657 FILM NUMBER: 161913018 BUSINESS ADDRESS: STREET 1: 20 INDEPENDENCE BOULEVARD CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 908-605-4700 MAIL ADDRESS: STREET 1: 20 INDEPENDENCE BOULEVARD CITY: WARREN STATE: NJ ZIP: 07059 D 1 primary_doc.xml X0707 D LIVE 0001472343 Roka BioScience, Inc. 20 INDEPENDENCE BOULEVARD WARREN NJ NEW JERSEY 07059 908-605-4700 DELAWARE None None Corporation true Lars Boesgaard c/o Roka BioScience, Inc. 20 Independence Boulevard, 4th Floor Warren NJ NEW JERSEY 07059 Executive Officer Paul G. Thomas c/o Roka BioScience, Inc. 20 Independence Boulevard, 4th Floor Warren NJ NEW JERSEY 07059 Executive Officer Director Jim Barret, PhD c/o Roka BioScience, Inc. 20 Independence Boulevard, 4th Floor Warren NJ NEW JERSEY 07059 Director David McGirr c/o Roka BioScience, Inc. 20 Independence Boulevard, 4th Floor Warren NJ NEW JERSEY 07059 Director Nicholas Valeriani c/o Roka BioScience, Inc. 20 Independence Boulevard, 4th Floor Warren NJ NEW JERSEY 07059 Director Jonathan Silverstein c/o Roka BioScience, Inc. 20 Independence Boulevard, 4th Floor Warren NJ NEW JERSEY 07059 Director Fred Cohen c/o Roka BioScience, Inc. 20 Independence Boulevard, 4th Floor Warren NJ NEW JERSEY 07059 Director Michael P. Doyle c/o Roka BioScience, Inc. 20 Independence Boulevard, 4th Floor Warren NJ NEW JERSEY 07059 Director Biotechnology Decline to Disclose 06b false 2016-09-21 false true true true Warrants and Preferred Stock convertible into Common Stock false 0 Roth Capital Partners, LLC 15407 None None 888 SAN CLEMENTE, SUITE 400 NEWPORT BEACH CA CALIFORNIA 92660 All States false 22500000 22500000 0 false 32 949850 0 Excludes warrants to purchase up to 2,366,858 shares of common stock. 0 true The proceeds are expected to be used for general corporate purposes which may include the payment of salaries and other fees to those listed in Item 3. false Roka BioScience, Inc. /s/ Lars Boesgaard Lars Boesgaard CFO & Treasurer 2016-09-30